Insights into TL1A and IBD pathogenesis

Advances in Experimental Medicine and Biology

Volumn 691, Issue , 2011, Pages 279-288

  Shih, David Q ^a   Michelsen, Kathrin S ^a   Barrett, Robert J ^a   Biener Ramanujan, Eva ^a   Gonsky, Rivkah ^a   Zhang, Xiaolan ^b   Targan, Stephan R ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH RECEPTOR 3; PROTEIN TL1A; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH INHIBITOR;

ADAPTIVE IMMUNITY; CONFERENCE PAPER; CROHN DISEASE; DISEASE SEVERITY; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; INNATE IMMUNITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TNFSF15 GENE; ULCERATIVE COLITIS; UPREGULATION; ANIMAL; BIOLOGICAL MODEL; ENTERITIS; GENETICS; METABOLISM; REVIEW;

ANIMALS; HUMANS; INFLAMMATORY BOWEL DISEASES; MODELS, BIOLOGICAL; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 25; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15;

EID: 79954427711     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-6612-4_29     Document Type: Conference Paper

References (42)

1. Aggarwal BB (2003) Signalling pathways of the TNF superfamily: A double-edged sword. Nat Rev Immunol 3:745-756
2. Arnott ID et al (2004) Sero-reactivity tomicrobial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am J Gastroenterol 99:2376-2384
3. Bamias G et al (2003) Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J Immunol 171:4868-4874
4. Barrett JC et al (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 40:955-962
5. Brand S et al (2006) IL-22 is increased in active Crohn's n disease and promotes proinflammatory gene expression and intestinal epithelia cell migration. Am J Physiol Gastrointest Liver Physiol 290:G827-G838
6. Bull MJ et al (2008) The Death Receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis. J Exp Med 205:2457-2464
7. Cassatella MA et al (2007) Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis. J Immunol 178:7325-7333
8. Cohavy O, Zhou J, Granger SW, Ware CF, Targan SR (2004) LIGHT expression by mucosal T cells may regulate IFN-gamma expression in the intestine. J Immunol 173:251-258
9. Croft M (2009) The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol 9:271-285
10. Endo K, Kinouchi Y, Kakuta Y, Ueki N, Takahashi S, Shimosegawa T (2009) Involvement of NF-kappa B pathway in TL1A gene expression induced by lipopolysaccharide. Cytokine
11. Fang L, Adkins B, Deyev V, Podack ER (2008) Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation. J Exp Med 205: 1037-1048
12. Fujino S et al (2003) Increased exprossion of interleukin 17 in inflammatory bowel disease. Gut 52:65-70
13. Furuya D et al (2002) Serum interlcukin-18 concentrations in patients with inflammatory bowel disease. J Immunother 25(Suppl 1):S65-S67
14. Kakuta Y, Kinouchi Y, Negoro K, Takahashi S, Shimosegawa T (2006) Association study of TNFSF15 polymorphisms in Japanese patients with inflammatory bowel disease. Gut 55:1527-1528
15. Kakuta Y et al (2009) TNFSF15 transcripts from risk haplotype for Crohn's disease are overexpressed in stimulated T cells. Hum Mol Genet 18:1089-1098
16. Kugathasan S et al (2008) Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat Genet 40:1211-1215
17. Meylan F et al (2008) The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Immunity 29:79-89
18. Michelsen KS et al (2009) IBD-associated TL1A gene (TNFSF15) haplotypes determine increased expression of TL1A protein. PLoS One 4:e4719
19. Migone TS et al (2002) TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16:479-492
20. Monteleone G et al (2005) Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease. Gastrocnterology 128:687-694
21. Mow WS et al (2004) Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology 126:414-424
22. Niclson OH, Rudiger N, Gaustadnes M, Horn T (1997) Intestinal interleukin-8 concentration and gene expression in inflammatory bowel disease. Scand J Gastroenterol 32:1028-1034
23. Papadakis KA et al (2003) CC chemokine receptor 9 expression defines a subset of peripheral blood lymphocytes with mucosal T cell phenotype and Th1 or T-regulatory 1 cytokine profile. J Immunol 171:159-165
24. Papadakis KA et al (2004) TL1A synergizes with IL-12 and IL-18 to enhance IFN-gamma production in human T cells and NK cells. J Immunol 172:7002-7007
25. Papadakis KA et al (2005) Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18- induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes. J Immunol 174:4985-4990
26. Pappu BP et al (2008) TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. J Exp Med 205:1049-1062
27. Picornell Y, Mei L, Taylor K, Yang H, Targan SR, Rotter JI (2007) TNFSF15 is an ethnicspecific IBD gene. Inflamm Bowel Dis 13:1333-1338
28. Prehn JL et al (2004) Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation. Clin Immunol 112:66-77
29. Prehn JL, Thomas LS, Landers CJ, Yu QT, Michelsen KS, Targan SR (2007) The T cell costimulator TL1A is induced by FcgammaR signaling in human monocytes and dendritic cells. J Immunol 178:4033-4038
30. Raddatz D, Bockemuhl M, Ramadori G (2005) Quantitative measurement of cytokine mRNA in inflammatory bowel disease: Relation to clinical and endoscopic activity and outcome. Eur J Gastroenterol Hepatol 17:547-557
31. Rutgeerts P et al (2005) Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 353:2462-2476
32. Saruta M, Michelsen KS, Thomas LS, Yu QT, Landers CJ, Targan SR (2009a) TLR8-mediated activation of human monocytes inhibits TL1A expression. Eur J Immunol 39:2195-2202
33. Saruta M, Targan SR, Mei L, Ippoliti AF, Taylor KD, Rotter JI (2009b) High-frequency haplotypes in the X chromosome locus TLR8 are associated with both CD and UC in females. Inflamm Bowel Dis 15:321-327
34. Schmidt C et al (2005) Expression of interleukin-12 related cytokine transcripts in inflammatory bowel disease: Elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis. Inflamm Bowel Dis 11:16-23
35. Shih DQ et al (2009) Microbial induction of inflammatory bowel disease associated gene TL1A (TNFSF15) in antigen presenting cells. Eur. J. Immunol 39:3239-3250
36. Shih DQ, Targan SR (2008) Immunopathogenesis of inflammatory bowel disease. World J Gastroenterol 14:390-400
37. Shih DQ, Targan SR, McGovern D (2008) Recent advances in IBD pathogenesis: Genetics and immunobiology. Curr Gastroenterol Rep 10:568-575
38. Takedatsu H et al (2008) TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology 135:552-567
39. Tan KB et al (1997) Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells. Gene 204:35-46
40. Targan SR et al (1997) A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 337:1029-1035
41. Tremelling M et al (2008) Contribution of TNFSF15 gene variants to Crohn's disease susceptibility confirmed in UK population. Inflamm Bowel Dis 14:733-737
42. Yamazaki K et al (2005) Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet 14:3499-3506